Literature DB >> 4337307

Control of Marek's disease in the Netherlands. I. Isolation of an avirulent Marek's disease virus (strain CVI 988) and its use in laboratory vaccination trials.

B H Rispens, H van Vloten, N Mastenbroek, H J Maas, K A Schat.   

Abstract

Entities:  

Mesh:

Substances:

Year:  1972        PMID: 4337307

Source DB:  PubMed          Journal:  Avian Dis        ISSN: 0005-2086            Impact factor:   1.577


× No keyword cloud information.
  52 in total

1.  Transactivation of latent Marek's disease herpesvirus genes in QT35, a quail fibroblast cell line, by herpesvirus of turkeys.

Authors:  T Yamaguchi; S L Kaplan; P Wakenell; K A Schat
Journal:  J Virol       Date:  2000-11       Impact factor: 5.103

2.  Expansion of a unique region in the Marek's disease virus genome occurs concomitantly with attenuation but is not sufficient to cause attenuation.

Authors:  R F Silva; S M Reddy; B Lupiani
Journal:  J Virol       Date:  2004-01       Impact factor: 5.103

3.  Marek's disease--the disease and its prevention by vaccination.

Authors:  P M Biggs
Journal:  Br J Cancer Suppl       Date:  1975-03

4.  Characterization of a very virulent Marek's disease virus mutant expressing the pp38 protein from the serotype 1 vaccine strain CVI988/Rispens.

Authors:  Lucy F Lee; Xiaoping Cui; Zhizhong Cui; Isabel Gimeno; Blanca Lupiani; Sanjay M Reddy
Journal:  Virus Genes       Date:  2005-08       Impact factor: 2.332

5.  Marek's disease virus phosphorylated polypeptide pp38 alters transcription rates of mitochondrial electron transport and oxidative phosphorylation genes.

Authors:  Michael S Piepenbrink; Xinhui Li; Priscilla H O'Connell; Karel A Schat
Journal:  Virus Genes       Date:  2009-05-27       Impact factor: 2.332

6.  Revaccination with Marek's disease vaccines induces productive infection and superior immunity.

Authors:  Changxin Wu; Junji Gan; Qiao Jin; Chuangfu Chen; Ping Liang; Yantao Wu; Xuefen Liu; Li Ma; Fred Davison
Journal:  Clin Vaccine Immunol       Date:  2008-12-03

7.  Clustering of mutations within the inverted repeat regions of a serially passaged attenuated gallid herpesvirus type 2 strain.

Authors:  Stephen J Spatz; Cary Rue; Daniel Schumacher; Nikolaus Osterrieder
Journal:  Virus Genes       Date:  2008-05-31       Impact factor: 2.332

8.  Loss of Marek's disease virus tumorigenicity is associated with truncation of RNAs transcribed within BamHI-H.

Authors:  G Bradley; G Lancz; A Tanaka; M Nonoyama
Journal:  J Virol       Date:  1989-10       Impact factor: 5.103

9.  Pathogenesis of Marek's disease in old chickens: lesion regression as the basis for age-related resistance.

Authors:  J M Sharma; R L Witter; B R Burmester
Journal:  Infect Immun       Date:  1973-11       Impact factor: 3.441

10.  The construction and characterization of the bi-directional promoter between pp38 gene and 1.8-kb mRNA transcripts of Marek's disease viruses.

Authors:  Ruiai Chen; Jiabo Ding; Bin Wang
Journal:  Virol J       Date:  2009-11-30       Impact factor: 4.099

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.